Efficacy and safety of novel and repurposed drugs for the treatment of drug-resistant tuberculosis
Background: There is widespread concern about the rise of drug-resistant TB because treatment outcomes of affected patients remain poor and treatment options are limited. After more than a forty-year gap without any breakthrough discovery, several new (bedaquiline and delamanid) and repurposed drugs...
Main Author: | |
---|---|
Other Authors: | |
Format: | Doctoral Thesis |
Language: | English |
Published: |
Faculty of Health Sciences
2020
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/32322 |